Patents Assigned to ALVOGEN, INC.
  • Controlled-release tablets, method of making, and method of use thereof
    Patent number: 11974974
    Abstract: Disclosed are gastroretentive, sustained-release tablet formulations comprising an active agent, such as pregabalin or a pharmaceutically acceptable form thereof, crospovidone, and a cationic copolymer based on dimethylaminoethyl methacrylate, butyl methacrylate, and methyl methacrylate random copolymer.
    Type: Grant
    Filed: July 1, 2020
    Date of Patent: May 7, 2024
    Assignee: ALVOGEN, INC.
    Inventors: Zhen Mei, Amit Shah, Mayank Joshi, Raghav K. Gupta